Description
Seeking men and women whose chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or non-Hodgkin's lymphoma can no longer be managed with the standard treatment for a study of the safety and effectiveness of an investigational drug.
Overview
We are studying what dose of an investigational drug for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or non-Hodgkin's lymphoma can be given to people without causing unacceptable side effects. The first group of participants in this study will receive a low dose of the the investigational drug and the next groups will get increasingly higher doses.
What we're hoping for
We hope to learn the best dose of the investigational drug to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or non-Hodgkin's lymphoma.
Additional Information
ClinicalTrials.gov Identifier: NCT03893682